AMANDA HALE: Open Payments
NPI 1235432519 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,369 in 103 payments from 45 companies in 2025. Trend: 2023 $3,679 · 2024 $2,494 · 2025 $2,369
Food & beverage: $2,256Education: $113
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $205 |
| Janssen Biotech, Inc. | 3 | $138 |
| Daiichi Sankyo Inc. | 7 | $137 |
| GENZYME CORPORATION | 4 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| Astellas Pharma US Inc | 5 | $109 |
| Stemline Therapeutics Inc. | 4 | $109 |
| Gilead Sciences, Inc. | 3 | $75 |
| Merck Sharp & Dohme LLC | 3 | $74 |
Products named: KISQALI, DARZALEX, IBRANCE, Orserdu, XTANDI, Trodelvy, KEYTRUDA, ZEPZELCA.
Industry payments across GA — which companies pay providers there.
